Turning Back Time: How to Make Our Cells Young Again!

The fountain of youth might just be a myth but it seems like we're getting there.

Hello, everyone! Have you ever wished you could turn back the clock on your body's cells, making them young and spry again? Well, scientists are working on something like a magic spell for our cells, and it's all about something called "epigenetic modifications." I know, that sounds like a mouthful, but I'll break it down so it's super easy to understand. Let's dive into a fascinating journey of rejuvenating our cells, combining what we've learned from two interesting articles on this topic!

What's Happening Inside Our Cells?

Imagine your body is like a big city, and the cells are the houses where all the action happens. Just like a house can get a bit dusty and rusty over time, our cells also wear out as we grow older. Scientists have found out that a big part of this "getting old" process is because of changes in something called "epigenetics."

Epigenetics is like the set of instructions that tells each cell in your body how to behave. It's not about changing the letters in your DNA book but more about which chapters are read and which are skipped. As we age, some of these instructions get a bit mixed up, leading to the signs of aging.

The Magic of Rejuvenation

Now, here's where the magic happens. Scientists have discovered ways to tweak these instructions—kind of like tidying up the messy parts—to make the cells act young again. This process is called "epigenetic modifications." By adjusting these epigenetic marks, we can potentially reverse the aging process in cells and make them behave like they did when they were younger.

Combining the Knowledge

Epigenetics involves changes in gene expression without altering the DNA sequence itself. This field studies how certain factors can switch genes on or off, influencing aging and the potential for reversing age-related decline. Scientists are particularly interested in how modifying these epigenetic markers can rejuvenate cells and potentially extend lifespan, offering a promising avenue for anti-aging interventions. The complexity and potential of manipulating these biological mechanisms to combat the effects of aging.

The intricate process of aging, presents as a complex biological phenomenon influenced by numerous factors. It explains that aging is not merely a superficial change but involves deep cellular and molecular alterations that affect the body's functionality over time. Thereis potential in understanding and manipulating these underlying processes to slow down or even reverse aging. It highlights advancements in the field of longevity science, including the exploration of interventions that could extend healthy lifespan by targeting the biological mechanisms responsible for aging, underscoring a future where aging could be more a controllable aspect of life.

We learn about these "epigenetic alterations" and how they're like small changes in the way our cells read their DNA instructions. Aging is not just about getting wrinkles or turning gray; it's about these deep, cellular changes that affect how we function as we get older.

By putting together the puzzle pieces, we see a picture where scientists are using our understanding of epigenetics to find ways to make old cells young again. It's like having a remote control with a "reverse" button for cellular aging!

Making It Happen

This all might sound like something out of a science fiction movie, but it's real science happening right now. Researchers are experimenting with ways to reset the epigenetic marks on cells, aiming to rejuvenate them and improve health and longevity. Imagine a world where we can not only live longer but also enjoy those extra years with the vitality of our youth!

What Does This Mean for Us?

While research is still in the early stages, it opens up exciting possibilities for the future of medicine and health care. We're talking about a future where treatments could potentially help our bodies heal faster, resist diseases better, and maybe even extend our lifespans in a significant way.

In Simple Terms

Think of your body as a garden. Over time, weeds grow (these are like the aging signs in our cells), and our garden doesn't look as vibrant as it used to. What scientists are doing with epigenetic modifications is akin to pulling out those weeds and planting new, young flowers, making the garden lively and colorful again.

Looking Ahead

While the road to practical applications is still long and filled with challenges, the promise of epigenetic modifications gives us hope. It's a glimpse into a future where aging might not mean losing our vitality and where we can look forward to not just more years in our life but more life in our years.

Conclusion

In wrapping up, the journey to understanding and potentially reversing aging through epigenetic modifications is an exciting field of science that's unfolding right before our eyes. By learning how to make our cells young again, we're opening the door to a future filled with health, vitality, and perhaps a bit of the fountain of youth's magic. Stay tuned, because the best is yet to come!

Reference:

Pereira, B., Correia, F. P., Alves, I. A., Costa, M., Gameiro, M., Martins, A. P., & Saraiva, J. A. (2024). Epigenetic reprogramming as a key to reverse ageing and increase longevity. Ageing research reviews, 95, 102204. Advance online publication.

Kane, A. E., & Sinclair, D. A. (2019). Epigenetic changes during aging and their reprogramming potential. Critical reviews in biochemistry and molecular biology, 54(1), 61–83.

Basu, A., & Tiwari, V. K. (2021). Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine. Clinical epigenetics, 13(1), 144.

Simpson, D. J., Olova, N. N., & Chandra, T. (2021). Cellular reprogramming and epigenetic rejuvenation. Clinical epigenetics, 13(1), 170.

Al Abbar, A., Ngai, S. C., Nograles, N., Alhaji, S. Y., & Abdullah, S. (2020). Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy. BioResearch open access, 9(1), 121–136.

Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., Yang, J. H., Zhou, S., Hoffmann, E. M., Karg, M. M., Schultz, M. B., Kane, A. E., Davidsohn, N., Korobkina, E., Chwalek, K., Rajman, L. A., … Sinclair, D. A. (2020). Reprogramming to recover youthful epigenetic information and restore vision. Nature, 588(7836), 124–129.

Chondronasiou, D., Gill, D., Mosteiro, L., Urdinguio, R. G., Berenguer-Llergo, A., Aguilera, M., Durand, S., Aprahamian, F., Nirmalathasan, N., Abad, M., Martin-Herranz, D. E., Stephan-Otto Attolini, C., Prats, N., Kroemer, G., Fraga, M. F., Reik, W., & Serrano, M. (2022). Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming. Aging cell, 21(3), e13578.

Alle, Q., Le Borgne, E., Bensadoun, P., Lemey, C., Béchir, N., Gabanou, M., Estermann, F., Bertrand-Gaday, C., Pessemesse, L., Toupet, K., Desprat, R., Vialaret, J., Hirtz, C., Noël, D., Jorgensen, C., Casas, F., Milhavet, O., & Lemaitre, J. M. (2022). A single short reprogramming early in life initiates and propagates an epigenetically related mechanism improving fitness and promoting an increased healthy lifespan. Aging cell, 21(11), e13714.

Cano Macip, C., Hasan, R., Hoznek, V.,, Kim, J., Metzger, IV, L.E., Sethna, S., Davidsohn, N., (2023) Gene Therapy Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice. bioRxiv

Ribeiro, R., Macedo, J. C., Costa, M., Ustiyan, V., Shindyapina, A. V., Tyshkovskiy, A., Gomes, R. N., Castro, J. P., Kalin, T. V., Vasques-Nóvoa, F., Nascimento, D. S., Dmitriev, S. E., Gladyshev, V. N., Kalinichenko, V. V., & Logarinho, E. (2022). In vivo cyclic induction of the FOXM1 transcription factor delays natural and progeroid aging phenotypes and extends healthspan. Nature aging, 2(5), 397–411.

Kim, Y., Jeong, J., & Choi, D. (2020). Small-molecule-mediated reprogramming: a silver lining for regenerative medicine. Experimental & molecular medicine, 52(2), 213–226.

Al-Haddad, R., Karnib, N., Assaad, R. A., Bilen, Y., Emmanuel, N., Ghanem, A., Younes, J., Zibara, V., Stephan, J. S., & Sleiman, S. F. (2016). Epigenetic changes in diabetes. Neuroscience letters, 625, 64–69.

Locke, W. J., Guanzon, D., Ma, C., Liew, Y. J., Duesing, K. R., Fung, K. Y. C., & Ross, J. P. (2019). DNA Methylation Cancer Biomarkers: Translation to the Clinic. Frontiers in genetics, 10, 1150.

Mitsumori, R., Sakaguchi, K., Shigemizu, D., Mori, T., Akiyama, S., Ozaki, K., Niida, S., & Shimoda, N. (2020). Lower DNA methylation levels in CpG island shores of CR1, CLU, and PICALM in the blood of Japanese Alzheimer’s disease patients. PloS one, 15(9), e0239196.

Luo, X., Hu, Y., Shen, J., Liu, X., Wang, T., Li, L., & Li, J. (2022). Integrative analysis of DNA methylation and gene expression reveals key molecular signatures in acute myocardial infarction. Clinical epigenetics, 14(1), 46.

Dhillon S. (2020). Decitabine/Cedazuridine: First Approval. Drugs, 80(13), 1373–1378.

Kaminskas, E., Farrell, A. T., Wang, Y. C., Sridhara, R., & Pazdur, R. (2005). FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension. The oncologist, 10(3), 176–182.

Kornicka, K., Marycz, K., Marędziak, M., Tomaszewski, K. A., & Nicpoń, J. (2017). The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells. Journal of cellular and molecular medicine, 21(2), 387–401.

Zhang, Z., Wang, G., Li, Y., Lei, D., Xiang, J., Ouyang, L., Wang, Y., & Yang, J. (2022). Recent progress in DNA methyltransferase inhibitors as anticancer agents. Frontiers in pharmacology, 13, 1072651.

Li, Q., Zhai, Y., Man, X., Zhang, S., & An, X. (2020). Inhibition of DNA Methyltransferase by RG108 Promotes Pluripotency-Related Character of Porcine Bone Marrow Mesenchymal Stem Cells. Cellular reprogramming, 22(2), 82–89.

Al-Mansour, F., Alraddadi, A., He, B., Saleh, A., Poblocka, M., Alzahrani, W., Cowley, S., & Macip, S. (2023). Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic. Aging, 15(7), 2373–2394.

Martin, L. J., Adams, D. A., Niedzwiecki, M. V., & Wong, M. (2022). Aberrant DNA and RNA Methylation Occur in Spinal Cord and Skeletal Muscle of Human SOD1 Mouse Models of ALS and in Human ALS: Targeting DNA Methylation Is Therapeutic. Cells, 11(21), 3448.

Scott, A. J., Ellison, M., & Sinclair, D. A. (2021). The economic value of targeting aging. Nature aging, 1(7), 616–623.